Skip to main content
VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc. — Investor Relations & Filings

Ticker · VYNE ISIN · US92941V1008 US Manufacturing
Filings indexed 608 across all filing types
Latest filing 2023-10-04 Director's Dealing
Country US United States of America
Listing US VYNE

About VYNE Therapeutics Inc.

https://vynetherapeutics.com/

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company's primary objective is to address unmet medical needs by advancing a pipeline of novel drug candidates. VYNE's approach centers on innovating beyond traditional assumptions to find improved solutions for patients with complex inflammatory and immunological diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2023-10-04 English
10-Q
Interim / Quarterly Report Q2 2023
2023-08-14 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key content is Item 2.02, which states that the company issued a press release announcing its financial results for the quarter ended June 30, 2023. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The document length is 3995 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, announcements of financial results in a Form 8-K with a press release attached are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2023-08-14 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-05 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-05 English
FORM 4 SUBMISSION
Director's Dealing
2023-07-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.